RESUMO
The present study was designed to investigate the effect of bacterial lipopolysaccharide (LPS) on C-C chemokine receptors (CCR) expressed in human mononuclear phagocytes. LPS caused a rapid and drastic reduction of CCR2 mRNA levels, which binds MCP-1 and -3. CCR1 and CCR5 mRNAs were also reduced, though to a lesser extent, whereas CXCR2 was unaffected. The rate of nuclear transcription of CCR2 was not affected by LPS, whereas the mRNA half life was reduced from 1.5 h to 45 min. As expected, LPS-induced inhibition of CCR2 mRNA expression was associated with a reduction of both MCP-1 binding and chemotactic responsiveness. The capacity to inhibit CCR2 expression in monocytes was shared by other microbial agents and cytokines (inactivated Streptococci, Propionibacterium acnes, and to a lesser extent, IL-1 and TNF-alpha). In contrast, IL-2 augmented CCR2 expression and MCP-1 itself had no effect. These results suggest that, regulation of receptor expression in addition to agonist production is likely a crucial point in the regulation of the chemokine system.
Assuntos
Citocinas , Regulação para Baixo , Lipopolissacarídeos/farmacologia , Monócitos/efeitos dos fármacos , Receptores de Quimiocinas , Receptores de Citocinas/biossíntese , Quimiocina CCL2/metabolismo , Quimiocina CCL7 , Quimiotaxia de Leucócito/efeitos dos fármacos , Humanos , Proteínas Quimioatraentes de Monócitos/metabolismo , RNA Mensageiro/metabolismo , Receptores CCR2 , Fatores de TempoRESUMO
The involvement of chemokines in inflammation is well established, but their functional role in disease progression, and particularly in the development of fibrosis, is not yet understood. To investigate the functional role that the chemokines monocyte chemoattractant protein-1 (MCP-1) and RANTES play in inflammation and the progression to fibrosis during crescentic nephritis we have developed and characterized a murine model for this syndrome. Significant increases in T-lymphocytes and macrophages were observed within glomeruli and interstitium, paralleled by an induction of mRNA expression of MCP-1 and RANTES, early after disease initiation. Blocking the function of MCP-1 or RANTES resulted in significant decreases in proteinuria as well as in numbers of infiltrating leukocytes, indicating that both MCP-1 and RANTES (regulated upon activation in normal T cells expressed and secreted) play an important role in the inflammatory phase of crescentic nephritis. In addition, neutralization of MCP-1 resulted in a dramatic decrease in both glomerular crescent formation and deposition of type I collagen. These results highlight a novel role for MCP-1 in crescent formation and development of interstitial fibrosis, and indicate that in addition to recruiting inflammatory cells this chemokine is critically involved in irreversible tissue damage.
Assuntos
Quimiocina CCL2 , Quimiocina CCL5 , Glomerulonefrite/etiologia , Animais , Colágeno/biossíntese , Colágeno/genética , Modelos Animais de Doenças , Progressão da Doença , Fibrose/etiologia , Imuno-Histoquímica , Rim/patologia , Camundongos , Proteinúria , RNA Mensageiro/análiseRESUMO
Dendritic cells are potent antigen-presenting cells involved in the initiation of immune responses. The trafficking of these cells to tissues and lymph nodes is mediated by members of the chemokine family. Recently, a novel CC chemokine known as MIP-3alpha or liver and activation-regulated chemokine has been identified from the EMBL/GenBank/DDBJ expressed sequence tag database. In the present study, we have shown that the messenger RNA for MIP-3alpha is expressed predominantly in inflamed and mucosal tissues. MIP-3alpha produced either synthetically or by human embryonic kidney 293 cells is chemotactic for CD34(+)-derived dendritic cells and T cells, but is inactive on monocytes and neutrophils. MIP-3alpha was unable to displace the binding of specific CC or CXC chemokines to stable cell lines expressing their respective high affinity receptors, namely CCR1-5 and CXCR1 and CXCR2, suggesting that MIP-3alpha acts through a novel CC chemokine receptor. Therefore, we used degenerate oligonucleotide-based reverse transcriptase PCR to identify candidate MIP-3alpha receptors in lung dendritic cells. Our results show that the orphan receptor known as GCY-4, CKRL-3, or STRL-22 is a specific receptor for MIP-3alpha, and that its activation leads to pertussis toxin-sensitive and phospholipase C-dependent intracellular Ca2+ mobilization when it is expressed in HEK 293 cells.
Assuntos
Quimiocinas CC , Células Dendríticas/imunologia , Pulmão/imunologia , Proteínas Inflamatórias de Macrófagos/metabolismo , Receptores de Quimiocinas , Receptores de Citocinas/genética , Sequência de Aminoácidos , Sequência de Bases , Ligação Competitiva , Cálcio/metabolismo , Linhagem Celular , Quimiocina CCL20 , Clonagem Molecular , Primers do DNA/genética , Células Dendríticas/metabolismo , Expressão Gênica , Humanos , Pulmão/metabolismo , Proteínas Inflamatórias de Macrófagos/genética , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores CCR6 , Receptores de Citocinas/metabolismo , Linfócitos T/imunologia , Linfócitos T/metabolismoRESUMO
Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5-dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5-dependent functional responses and reveals distinct mechanisms of receptor/cellular activation.
Assuntos
Eosinófilos/imunologia , Interleucina-5/imunologia , Células Cultivadas , Humanos , Interleucina-5/genética , Mutação , Receptores de Interleucina/imunologia , Receptores de Interleucina-5 , Transdução de Sinais/genética , Transdução de Sinais/imunologiaRESUMO
CCR5, a chemokine receptor expressed on T cells and macrophages, is the principal coreceptor for M-tropic HIV-1 strains. Recently, we described an NH2-terminal modification of the CCR5 ligand regulated on activation, normal T cell expressed and secreted (RANTES), aminooxypentane-RANTES (AOP-RANTES), that showed potent inhibition of macrophage infection by HIV-1 under conditions where RANTES was barely effective. To investigate the mechanism of AOP-RANTES inhibition of HIV infectivity we examined the surface expression of CCR5 using a monoclonal anti-CCR5 antibody, MC-1. We demonstrate that AOP-RANTES rapidly caused >90% decrease in cell surface expression of CCR5 on lymphocytes, monocytes/ macrophages, and CCR5 transfected Chinese hamster ovary (CHO) cells. RANTES also caused a loss of cell surface CCR5, although its effect was less than with AOP-RANTES. Significantly, AOP-RANTES inhibited recycling of internalized CCR5 to the cell surface, whereas RANTES did not. When peripheral blood mononuclear cells are cultured for prolonged periods of time in the presence of RANTES, CCR5 expression is comparable to that seen on cells treated with control medium, whereas there is no CCR5 surface expression on cells cultured in the presence of AOP-RANTES. Immunofluorescence indicated that both AOP-RANTES and RANTES induced downmodulation of cell surface CCR5, and that the receptor was redistributed into endocytic organelles containing the transferrin receptor. When RANTES was removed, the internalized receptor was recycled to the cell surface; however, the receptor internalized in the presence of AOP-RANTES was retained in endosomes. Using human osteosarcoma (GHOST) 34/CCR5 cells, the potency of AOP-RANTES and RANTES to inhibit infection by the M-tropic HIV-1 strain, SF 162, correlated with the degree of downregulation of CCR5 induced by the two chemokines. These differences between AOP-RANTES and RANTES in their effect on receptor downregulation and recycling suggest a mechanism for the potent inhibition of HIV infection by AOP-RANTES. Moreover, these results support the notion that receptor internalization and inhibition of receptor recycling present new targets for therapeutic agents to prevent HIV infection.
Assuntos
Fármacos Anti-HIV/farmacologia , Quimiocina CCL5/análogos & derivados , HIV-1/efeitos dos fármacos , Receptores CCR5/metabolismo , Animais , Transporte Biológico , Células CHO , Quimiocina CCL5/farmacologia , Cricetinae , Regulação para Baixo , Endocitose , Endossomos/metabolismo , HumanosRESUMO
A key rate-limiting step in the adaptive immune response at peripheral challenge sites is the transmission of antigen signals to T cells in regional lymph nodes. Recent evidence suggests that specialized dendritic cells (DC) fulfill this surveillance function in the resting state, but their relatively slow turnover in most peripheral tissues brings into question their effectiveness in signaling the arrival of highly pathogenic sources of antigen which require immediate mobilization of the full range of host defenses for maintenance of homeostasis. However, the present report demonstrates that recruitment of a wave of DC into the respiratory tract mucosa is a universal feature of the acute cellular response to local challenge with bacterial, viral, and soluble protein antigens. Consistent with this finding, we also demonstrate that freshly isolated respiratory mucosal DC respond in vitro to a variety of CC chemokines as well as complementary cleavage products and N-formyl-methionyl-leucine-phenylalanine. This suggests that rapid amplification of specific antigen surveillance at peripheral challenge sites is an integral feature of the innate immune response at mucosal surfaces, and serves as an "early warning system" to alert the adaptive immune system to incoming pathogens.
Assuntos
Células Dendríticas/imunologia , Inflamação/imunologia , Infecções Respiratórias/imunologia , Animais , Antígenos/imunologia , Bordetella pertussis , Quimiocinas/farmacologia , Células Dendríticas/efeitos dos fármacos , Epitélio/imunologia , Moraxella catarrhalis , Mucosa/imunologia , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Infecções por Neisseriaceae/imunologia , Ovalbumina/imunologia , Ratos , Ratos Endogâmicos , Respirovirus , Infecções por Respirovirus/imunologia , Linfócitos T/imunologia , Coqueluche/imunologiaRESUMO
CC chemokine receptor (CCR)4, a high affinity receptor for the CC chemokines thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), is expressed in the thymus and spleen, and also by peripheral blood T cells, macrophages, platelets, and basophils. Recent studies have shown that CCR4 is the major chemokine receptor expressed by T helper type 2 (Th2) polarized cells. To study the in vivo role of CCR4, we have generated CCR4-deficient (CCR4(-/-)) mice by gene targeting. CCR4(-/-) mice developed normally. Splenocytes and thymocytes isolated from the CCR4(-/-) mice failed to respond to the CCR4 ligands TARC and MDC, as expected, but also surprisingly did not undergo chemotaxis in vitro in response to macrophage inflammatory protein (MIP)-1alpha. The CCR4 deletion had no effect on Th2 differentiation in vitro or in a Th2-dependent model of allergic airway inflammation. However, CCR4(-/-) mice exhibited significantly decreased mortality on administration of high or low dose bacterial lipopolysaccharide (LPS) compared with CCR4(+/+) mice. After high dose LPS treatment, serum levels of tumor necrosis factor alpha, interleukin 1beta, and MIP-1alpha were reduced in CCR4(-/-) mice, and decreased expression of MDC and MIP-2 mRNA was detected in peritoneal exudate cells. Analysis of peritoneal lavage cells from CCR4(-/)- mice by flow cytometry also revealed a significant decrease in the F4/80(+) cell population. This may reflect a defect in the ability of the CCR4(-/-) macrophages to be retained in the peritoneal cavity. Taken together, our data reveal an unexpected role for CCR4 in the inflammatory response leading to LPS-induced lethality.
Assuntos
Quimiocinas CC/metabolismo , Receptores de Quimiocinas/metabolismo , Choque Séptico/imunologia , Linfócitos T/imunologia , Animais , Sequência de Bases , Quimiocina CCL17 , Quimiocina CCL22 , Primers do DNA/genética , Lipopolissacarídeos/toxicidade , Macrófagos/imunologia , Macrófagos/patologia , Camundongos , Camundongos Knockout , Receptores CCR4 , Receptores de Quimiocinas/deficiência , Receptores de Quimiocinas/genética , Choque Séptico/patologia , Choque Séptico/prevenção & controle , Células Th2/imunologiaRESUMO
The complex pathophysiology of lung allergic inflammation and bronchial hyperresponsiveness (BHR) that characterize asthma is achieved by the regulated accumulation and activation of different leukocyte subsets in the lung. The development and maintenance of these processes correlate with the coordinated production of chemokines. Here, we have assessed the role that different chemokines play in lung allergic inflammation and BHR by blocking their activities in vivo. Our results show that blockage of each one of these chemokines reduces both lung leukocyte infiltration and BHR in a substantially different way. Thus, eotaxin neutralization reduces specifically BHR and lung eosinophilia transiently after each antigen exposure. Monocyte chemoattractant protein (MCP)-5 neutralization abolishes BHR not by affecting the accumulation of inflammatory leukocytes in the airways, but rather by altering the trafficking of the eosinophils and other leukocytes through the lung interstitium. Neutralization of RANTES (regulated upon activation, normal T cell expressed and secreted) receptor(s) with a receptor antagonist decreases significantly lymphocyte and eosinophil infiltration as well as mRNA expression of eotaxin and RANTES. In contrast, neutralization of one of the ligands for RANTES receptors, macrophage-inflammatory protein 1alpha, reduces only slightly lung eosinophilia and BHR. Finally, MCP-1 neutralization diminishes drastically BHR and inflammation, and this correlates with a pronounced decrease in monocyte- and lymphocyte-derived inflammatory mediators. These results suggest that different chemokines activate different cellular and molecular pathways that in a coordinated fashion contribute to the complex pathophysiology of asthma, and that their individual blockage results in intervention at different levels of these processes.
Assuntos
Quimiocinas CC/fisiologia , Hipersensibilidade/imunologia , Inflamação/imunologia , Pulmão/imunologia , Animais , Anticorpos/imunologia , Asma/fisiopatologia , Quimiocina CCL11 , Quimiocina CCL4 , Quimiocina CCL5/farmacologia , Quimiocinas CC/antagonistas & inibidores , Fatores Quimiotáticos de Eosinófilos/farmacologia , Citocinas/farmacologia , Modelos Animais de Doenças , Imuno-Histoquímica , Leucócitos/efeitos dos fármacos , Leucócitos/metabolismo , Pulmão/citologia , Proteínas Inflamatórias de Macrófagos/farmacologia , Camundongos , Camundongos Endogâmicos , Proteínas Quimioatraentes de Monócitos/farmacologia , Ovalbumina/imunologia , RNA Mensageiro/metabolismoRESUMO
The immunosuppressive and antiinflammatory cytokine interleukin (IL) 10 selectively upregulates the expression of the CC chemokine receptors CCR5, 2, and 1 in human monocytes by prolonging their mRNA half-life. IL-10-stimulated monocytes display an increased number of cell surface receptors for, and better chemotactic responsiveness to, relevant agonists than do control cells. In addition, IL-10-stimulated monocytes are more efficiently infected by HIV BaL. This effect was associated to the enhancement of viral entry through CCR5. These data add support to an emerging paradigm in which pro- and antiinflammatory molecules exert reciprocal and opposing influence on chemokine agonist production and receptor expression.
Assuntos
Infecções por HIV/virologia , Interleucina-10/farmacologia , Monócitos/virologia , Receptores CCR5/metabolismo , Northern Blotting , DNA Viral/metabolismo , Citometria de Fluxo , Regulação da Expressão Gênica/genética , Humanos , Cinética , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Receptores CCR1 , Receptores CCR5/genética , Receptores de Quimiocinas/genética , Regulação para Cima/efeitos dos fármacosRESUMO
Challenge of the airways of sensitized guinea pigs with aerosolized ovalbumin resulted in an early phase of microvascular protein leakage and a delayed phase of eosinophil accumulation in the airway lumen, as measured using bronchoalveolar lavage (BAL). Immunoreactive eotaxin levels rose in airway tissue and BAL fluid to a peak at 6 h falling to low levels by 12 h. Eosinophil numbers in the tissue correlated with eotaxin levels until 6 h but eosinophils persisted until the last measurement time point at 24 h. In contrast, few eosinophils appeared in BAL over the first 12 h, major trafficking through the airway epithelium occurring at 12-24 h when eotaxin levels were low. Constitutive eotaxin was present in BAL fluid. Both constitutive and allergen-induced eosinophil chemoattractant activity in BAL fluid was neutralized by an antibody to eotaxin. Allergen-induced eotaxin appeared to be mainly in airway epithelium and macrophages, as detected by immunostaining. Allergen challenge of the lung resulted in a rapid release of bone marrow eosinophils into the blood. An antibody to IL-5 suppressed bone marrow eosinophil release and lung eosinophilia, without affecting lung eotaxin levels. Thus, IL-5 and eotaxin appear to cooperate in mediating a rapid transfer of eosinophils from the bone marrow to the lung in response to allergen challenge.
Assuntos
Asma/fisiopatologia , Quimiocinas CC , Fatores Quimiotáticos de Eosinófilos/biossíntese , Citocinas/biossíntese , Eosinófilos/fisiologia , Animais , Células da Medula Óssea , Líquido da Lavagem Broncoalveolar/química , Quimiocina CCL11 , Citocinas/análise , Dexametasona/farmacologia , Feminino , Cobaias , Interleucina-5/fisiologia , Pulmão/patologia , Masculino , Albumina Sérica/análiseRESUMO
Chemokines are a family of proinflammatory cytokines that attract and activate specific types of leukocytes. Chemokines mediate their effects via interaction with seven transmembrane G protein-coupled receptors (GPCR). Using CCR5-transfected HEK-293 cells, we show that both the CCR5 ligand, RANTES, as well as its derivative, aminooxypentane (AOP)- RANTES, trigger immediate responses such as Ca2+ influx, receptor dimerization, tyrosine phosphorylation, and Galphai as well as JAK/STAT association to the receptor. In contrast to RANTES, (AOP)-RANTES is unable to trigger late responses, as measured by the association of focal adhesion kinase (FAK) to the chemokine receptor complex, impaired cell polarization required for migration, or chemotaxis. The results are discussed in the context of the dissociation of the late signals, provoked by the chemokines required for cell migration, from early signals.
Assuntos
Quimiocina CCL5/análogos & derivados , Quimiocina CCL5/fisiologia , Quimiotaxia/fisiologia , Proteínas do Leite , Transdução de Sinais/fisiologia , Moléculas de Adesão Celular/metabolismo , Linhagem Celular , Proteínas de Ligação a DNA/metabolismo , Quinase 1 de Adesão Focal , Proteína-Tirosina Quinases de Adesão Focal , Proteínas de Ligação ao GTP/metabolismo , Humanos , Janus Quinase 1 , Fosforilação , Proteínas Tirosina Quinases/metabolismo , Receptores CCR5/genética , Receptores CCR5/fisiologia , Fator de Transcrição STAT5 , Transativadores/metabolismo , Transfecção , Tirosina/metabolismoRESUMO
The chemokine receptor CXCR4 is required, together with CD4, for entry by some isolates of HIV-1, particularly those that emerge late in infection. The use of CXCR4 by these viruses likely has profound effects on viral host range and correlates with the evolution of immunodeficiency. Stromal cell-derived factor-1 (SDF-1), the ligand for CXCR4, can inhibit infection by CXCR4-dependent viruses. To understand the mechanism of this inhibition, we used a monoclonal antibody that is specific for CXCR4 to analyze the effects of phorbol esters and SDF-1 on surface expression of CXCR4. On human T cell lines SupT1 and BC7, CXCR4 undergoes slow constitutive internalization (1.0% of the cell surface pool/min). Addition of phorbol esters increased this endocytosis rate >6-fold and reduced cell surface CXCR4 expression by 60 to 90% over 120 min. CXCR4 was internalized through coated pits and coated vesicles and subsequently localized in endosomal compartments from where it could recycle to the cell surface after removal of the phorbol ester. SDF-1 also induced the rapid down modulation (half time approximately 5 min) of CXCR4. Using mink lung epithelial cells expressing CXCR4 and a COOH-terminal deletion mutant of CXCR4, we found that an intact cytoplasmic COOH-terminal domain was required for both PMA and ligand-induced CXCR4 endocytosis. However, experiments using inhibitors of protein kinase C indicated that SDF-1 and phorbol esters trigger down modulation through different cellular mechanisms. SDF-1 inhibited HIV-1 infection of mink cells expressing CD4 and CXCR4. The inhibition of infection was less efficient for CXCR4 lacking the COOH-terminal domain, suggesting at least in part that SDF-1 inhibition of virus infection was mediated through ligand-induced internalization of CXCR4. Significantly, ligand induced internalization of CXCR4 but not CD4, suggesting that CXCR4 and CD4 do not normally physically interact on the cell surface. Together these studies indicate that endocytosis can regulate the cell-surface expression of CXCR4 and that SDF-1-mediated down regulation of cell-surface coreceptor expression contributes to chemokine-mediated inhibition of HIV infection.
Assuntos
Quimiocinas CXC , Quimiocinas/farmacologia , Regulação para Baixo/efeitos dos fármacos , Endocitose/efeitos dos fármacos , Ésteres de Forbol/farmacologia , Receptores CXCR4/fisiologia , Animais , Anticorpos Monoclonais/metabolismo , Anticorpos Monoclonais/fisiologia , Sítios de Ligação de Anticorpos , Ligação Competitiva , Células CHO , Linhagem Celular , Membrana Celular/fisiologia , Quimiocina CXCL12 , Clatrina/fisiologia , Invaginações Revestidas da Membrana Celular/fisiologia , Cricetinae , Endossomos/efeitos dos fármacos , Endossomos/metabolismo , Humanos , Vison , Receptores CXCR4/biossíntese , Receptores CXCR4/imunologia , Rabdomiossarcoma , Células Estromais/fisiologia , Linfócitos T/metabolismo , Linfócitos T/fisiologia , Transfecção , Células Tumorais CultivadasRESUMO
The chemokine receptors CXCR4 and CCR5 have recently been shown to act as coreceptors, in concert with CD4, for human immunodeficiency virus-type 1 (HIV-1) infection. RANTES and other chemokines that interact with CCR5 and block infection of peripheral blood mononuclear cell cultures inhibit infection of primary macrophages inefficiently at best. If used to treat HIV-1-infected individuals, these chemokines could fail to influence HIV replication in nonlymphocyte compartments while promoting unwanted inflammatory side effects. A derivative of RANTES that was created by chemical modification of the amino terminus, aminooxypentane (AOP)-RANTES, did not induce chemotaxis and was a subnanomolar antagonist of CCR5 function in monocytes. It potently inhibited infection of diverse cell types (including macrophages and lymphocytes) by nonsyncytium-inducing, macrophage-tropic HIV-1 strains. Thus, activation of cells by chemokines is not a prerequisite for the inhibition of viral uptake and replication. Chemokine receptor antagonists like AOP-RANTES that achieve full receptor occupancy at nanomolar concentrations are strong candidates for the therapy of HIV-1-infected individuals.
Assuntos
HIV-1/efeitos dos fármacos , Macrófagos/virologia , Receptores de Quimiocinas , Receptores de Citocinas/antagonistas & inibidores , Receptores de HIV/antagonistas & inibidores , Linfócitos T/virologia , Animais , Ligação Competitiva , Antígenos CD4/metabolismo , Gatos , Linhagem Celular , Células Cultivadas , Quimiocina CCL4 , Quimiocina CCL5/metabolismo , Quimiocina CCL5/farmacologia , Quimiotaxia de Leucócito , HIV-1/fisiologia , Células HeLa , Humanos , Proteínas Inflamatórias de Macrófagos/metabolismo , Macrófagos/efeitos dos fármacos , Receptores CCR5 , Receptores de Citocinas/metabolismo , Receptores de HIV/metabolismo , Linfócitos T/efeitos dos fármacos , Replicação Viral/efeitos dos fármacosRESUMO
Kaposi's sarcoma-associated herpesvirus encodes a chemokine called vMIP-II. This protein displayed a broader spectrum of receptor activities than any mammalian chemokine as it bound with high affinity to a number of both CC and CXC chemokine receptors. Binding of vMIP-II, however, was not associated with the normal, rapid mobilization of calcium from intracellular stores; instead, it blocked calcium mobilization induced by endogenous chemokines. In freshly isolated human monocytes the virally encoded vMIP-II acted as a potent and efficient antagonist of chemotaxis induced by chemokines. Because vMIP-II could inhibit cell entry of human immunodeficiency virus (HIV) mediated through CCR3 and CCR5 as well as CXCR4, this protein may serve as a lead for development of broad-spectrum anti-HIV agents.
Assuntos
Quimiocinas/antagonistas & inibidores , Quimiocinas/metabolismo , Herpesvirus Humano 8/genética , Receptores de Citocinas/metabolismo , Receptores de HIV/metabolismo , Sequência de Aminoácidos , Animais , Cálcio/metabolismo , Linhagem Celular , Quimiocina CCL5/antagonistas & inibidores , Quimiocinas/química , Quimiocinas/genética , Quimiocinas/farmacologia , Quimiotaxia de Leucócito , HIV-1/fisiologia , Humanos , Dados de Sequência Molecular , Monócitos/citologia , Receptores de Citocinas/antagonistas & inibidores , Receptores de HIV/antagonistas & inibidores , Proteínas Recombinantes/farmacologia , Transdução de SinaisRESUMO
Selective eosinophil recruitment into tissues is a characteristic feature of allergic diseases. Chemokines are effective leukocyte chemoattractants and may play an important role in mediating eosinophil recruitment in various allergic conditions in man. Here, we describe a novel mouse model of eosinophil recruitment in which we have compared the in vivo chemoattractant activity of different C-C chemokines. Furthermore, we describe the use of antibodies to chemokines and receptor blockade to address the endogenous mechanisms involved in eosinophil recruitment in a late-phase allergic reaction in mouse skin. Intradermal injection of mEotaxin and mMIP-1alpha, but not mMCP-1, mRANTES, mMCP-5, or mMIP-1beta, induced significant 111In-eosinophil recruitment in mouse skin. Significant 111In-eosinophil recruitment was also observed in an active cutaneous anaphylactic reaction. Pretreatment of skin sites with antieotaxin antiserum, but not an antiMIP-1alpha antibody, suppressed 111In-eosinophil recruitment in this delayed-onset allergic reaction. Similarly, desensitization of the eosinophil eotaxin receptor CCR3 with mEotaxin, or blockade of the receptor with metRANTES, significantly inhibited 111In-eosinophil recruitment in the allergic reaction. These results demonstrate an important role for endogenous eotaxin in mediating the 111In-eosinophil recruitment in allergic inflammation, and suggest that blockade of the CCR3 receptor is a valid strategy to inhibit eosinophil migration in vivo.
Assuntos
Quimiocinas CC/farmacologia , Quimiotaxia de Leucócito , Eosinófilos/imunologia , Hipersensibilidade/imunologia , Pele/imunologia , Anafilaxia/imunologia , Animais , Quimiocina CCL11 , Fatores Quimiotáticos de Eosinófilos/metabolismo , Complemento C5a/farmacologia , Citocinas/metabolismo , Feminino , Hipersensibilidade Tardia/imunologia , Leucotrieno B4/farmacologia , Camundongos , Camundongos Endogâmicos CBA , Fator de Ativação de Plaquetas/farmacologia , Receptores CCR3 , Receptores de Quimiocinas/metabolismoRESUMO
Chemokines and their receptors are at the core of many processes in biology, from routine immunosurveillance and the inflammatory process, through to the infection of cells by HIV. In the past two years, various bioinformatic and cloning strategies have led to an explosion in the number of chemokines and receptors that have been identified. Although the picture is far from complete, several themes are emerging. In particular, there are important differences between observations in vitro, where there appears to be much redundancy, and studies in vivo, where distinct roles are clearer. In this review, Timothy Wells, Christine Power and Amanda Proudfoot discuss the chemokines and their receptors and recent data from immunological and virology studies, and speculate on the potential of interfering with the chemokine network as a useful approach to ameliorating disease.
Assuntos
Quimiocinas/fisiologia , Receptores de Quimiocinas/fisiologia , Antígenos CD/imunologia , Antígenos CD/fisiologia , Doenças Autoimunes/imunologia , Doenças Autoimunes/fisiopatologia , Proteínas de Ligação ao GTP/imunologia , Infecções por HIV/imunologia , Infecções por HIV/fisiopatologia , Humanos , Poxviridae/imunologia , Receptores de Quimiocinas/imunologia , Receptores de Interleucina/imunologia , Receptores de Interleucina/fisiologia , Receptores de Interleucina-8A , Simplexvirus/imunologia , Linfócitos T/imunologiaRESUMO
Chemokines are a large family of cytokines with a wide variety of biological actions. Originally, they were identified as controllers of the routine trafficking of immune cells, and directed migration of cells during inflammatory response - from which they get their name, a contraction of chemotactic cytokines. They are now also known to be active in angiogenesis, embryonic development and infection by viruses such as HIV-1. Studies with antibodies, modified chemokine and transgenic mice suggest that chemokine receptor antagonists may be selective anti-inflammatory, antiviral or immunomodulatory agents. Small-molecule antagonists of seven of the receptors have been reported, some with potency in the low nanomolar range. These compounds are shown to be active in cell biology assays; the next step will be to determine their efficacy in animal models of disease.
Assuntos
Quimiocinas/antagonistas & inibidores , Desenho de Fármacos , Animais , Anticorpos/imunologia , Quimiocinas/química , Quimiocinas/metabolismo , Humanos , Camundongos , Camundongos Knockout , Sondas Moleculares , Receptores de Quimiocinas/imunologia , Receptores de Quimiocinas/metabolismo , Receptores de Quimiocinas/fisiologiaRESUMO
Scanning tunnelling microscopy (STM) has been used to examine the shape of individual immunoglobulin G (IgG) molecules deposited onto a graphite surface. IgG was chosen for this study as it has a well-characterized and distinctive three-dimensional structure. The micrographs clearly reveal the IgG molecule as trilobed, corresponding with the known structural organization of IgG. Comparison of these images with the structure of IgG determined by X-ray crystallography shows that the STM images are consistent with the crystal structure. This illustrates that STM is a valuable technique for examining protein structure, allowing rapid determination of the overall molecular shape that is consistent with more established techniques.
Assuntos
Imunoglobulina G/ultraestrutura , Imunoglobulina G/química , Microscopia de Tunelamento , Conformação Proteica , Difração de Raios XRESUMO
The chemotactic cytokine RANTES (Regulated on Activation, Normal T-cell Expressed and Secreted) is a potent chemoattractant and activator of a number of leukocytes, with a molecular mass of 8 kDa. Crystals of this protein have been grown from 100 mM sodium acetate buffer (pH 4.6) containing 200 mM magnesium acetate, with 20% (w/v) PEG 4000 and 6% (v/v) glycerol. The crystals grow as thick rods, which diffract to at least 1.8 A resolution on a rotating anode X-ray source. The crystals belong to space group p2(1)2(1)2(1) with unit cell dimensions a = 95.14 A, b = 57.58 A and c = 24.01 A with alpha = beta = gamma = 90 degrees. The asymmetric unit contains two molecules of the RANTES monomer, with a VM of 2.0 A(3)/Da.
Assuntos
Linfocinas/química , Quimiocina CCL5 , Humanos , Proteínas Recombinantes/química , Difração de Raios XRESUMO
Crystals of recombinant phosphomannose isomerase from Candida albicans have been obtained in a form suitable for X-ray diffraction analysis. The enzyme plays a key role in the biosynthesis of the mannan component of the fungal cell wall. It crystallizes in monoclinic space group C2, with cell dimensions a = 124.9 A, b = 52.9 A, c = 85.9 A and beta = 127.4 degrees. The crystals diffract to Bragg spacings beyond 1.7 A, native data have been collected to 2.4 A and a search for heavy-metal derivatives is in progress. The asymmetric unit contains one molecule of the enzyme (M(r) approximately 49,000) with a Vm of 2.3 A3/Da.